
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Epidermal growth factor receptor: Structure-function informing the design of anticancer therapeutics
Ruth A. Mitchell, Rodney B. Luwor, Antony W. Burgess
Experimental Cell Research (2018) Vol. 371, Iss. 1, pp. 1-19
Closed Access | Times Cited: 87
Ruth A. Mitchell, Rodney B. Luwor, Antony W. Burgess
Experimental Cell Research (2018) Vol. 371, Iss. 1, pp. 1-19
Closed Access | Times Cited: 87
Showing 1-25 of 87 citing articles:
Nanotechnology-based delivery of CRISPR/Cas9 for cancer treatment
Xiaoyu Xu, Chang Liu, Yonghui Wang, et al.
Advanced Drug Delivery Reviews (2021) Vol. 176, pp. 113891-113891
Open Access | Times Cited: 181
Xiaoyu Xu, Chang Liu, Yonghui Wang, et al.
Advanced Drug Delivery Reviews (2021) Vol. 176, pp. 113891-113891
Open Access | Times Cited: 181
Epithelial‐to‐mesenchymal transition in oral squamous cell carcinoma: Challenges and opportunities
Zihang Ling, Bin Cheng, Xiaoan Tao
International Journal of Cancer (2020) Vol. 148, Iss. 7, pp. 1548-1561
Open Access | Times Cited: 163
Zihang Ling, Bin Cheng, Xiaoan Tao
International Journal of Cancer (2020) Vol. 148, Iss. 7, pp. 1548-1561
Open Access | Times Cited: 163
Structural Insight and Development of EGFR Tyrosine Kinase Inhibitors
Tasia Amelia, Rahmana Emran Kartasasmita, Tomohiko Ohwada, et al.
Molecules (2022) Vol. 27, Iss. 3, pp. 819-819
Open Access | Times Cited: 73
Tasia Amelia, Rahmana Emran Kartasasmita, Tomohiko Ohwada, et al.
Molecules (2022) Vol. 27, Iss. 3, pp. 819-819
Open Access | Times Cited: 73
Carboranes as unique pharmacophores in antitumor medicinal chemistry
Yu Chen, Fukuan Du, Liyao Tang, et al.
Molecular Therapy — Oncolytics (2022) Vol. 24, pp. 400-416
Open Access | Times Cited: 71
Yu Chen, Fukuan Du, Liyao Tang, et al.
Molecular Therapy — Oncolytics (2022) Vol. 24, pp. 400-416
Open Access | Times Cited: 71
The universe of galectin-binding partners and their functions in health and disease
María F. Troncoso, María T. Elola, Ada G. Blidner, et al.
Journal of Biological Chemistry (2023) Vol. 299, Iss. 12, pp. 105400-105400
Open Access | Times Cited: 45
María F. Troncoso, María T. Elola, Ada G. Blidner, et al.
Journal of Biological Chemistry (2023) Vol. 299, Iss. 12, pp. 105400-105400
Open Access | Times Cited: 45
Molecular mechanism of genetic, epigenetic, and metabolic alteration in lung cancer
Shahab Fatima, Vineet Kumar, Dhruv Kumar
Medical Oncology (2025) Vol. 42, Iss. 3
Closed Access | Times Cited: 2
Shahab Fatima, Vineet Kumar, Dhruv Kumar
Medical Oncology (2025) Vol. 42, Iss. 3
Closed Access | Times Cited: 2
Molecular Targeting of Epidermal Growth Factor Receptor (EGFR) and Vascular Endothelial Growth Factor Receptor (VEGFR)
Nichole E. M. Kaufman, Simran Dhingra, Seetharama D. Jois, et al.
Molecules (2021) Vol. 26, Iss. 4, pp. 1076-1076
Open Access | Times Cited: 75
Nichole E. M. Kaufman, Simran Dhingra, Seetharama D. Jois, et al.
Molecules (2021) Vol. 26, Iss. 4, pp. 1076-1076
Open Access | Times Cited: 75
Next-generation EGFR tyrosine kinase inhibitors to overcome C797S mutation in non-small cell lung cancer (2019–2024)
Debasis Das, Lingzhi Xie, Hong Jian
RSC Medicinal Chemistry (2024)
Closed Access | Times Cited: 13
Debasis Das, Lingzhi Xie, Hong Jian
RSC Medicinal Chemistry (2024)
Closed Access | Times Cited: 13
Targeting HER2 in solid tumors: Unveiling the structure and novel epitopes
Xinlin Liu, Yunlong Song, Panpan Cheng, et al.
Cancer Treatment Reviews (2024) Vol. 130, pp. 102826-102826
Closed Access | Times Cited: 8
Xinlin Liu, Yunlong Song, Panpan Cheng, et al.
Cancer Treatment Reviews (2024) Vol. 130, pp. 102826-102826
Closed Access | Times Cited: 8
Actively targeted nanocarriers for drug delivery to cancer cells
Stefania Biffi, Rebecca Voltan, Barbara Bortot, et al.
Expert Opinion on Drug Delivery (2019) Vol. 16, Iss. 5, pp. 481-496
Open Access | Times Cited: 65
Stefania Biffi, Rebecca Voltan, Barbara Bortot, et al.
Expert Opinion on Drug Delivery (2019) Vol. 16, Iss. 5, pp. 481-496
Open Access | Times Cited: 65
Natural tyrosine kinase inhibitors acting on the epidermal growth factor receptor: Their relevance for cancer therapy
Yuan Liang, Tiehua Zhang, Jie Zhang
Pharmacological Research (2020) Vol. 161, pp. 105164-105164
Closed Access | Times Cited: 56
Yuan Liang, Tiehua Zhang, Jie Zhang
Pharmacological Research (2020) Vol. 161, pp. 105164-105164
Closed Access | Times Cited: 56
Advances in targeting EGFR allosteric site as anti-NSCLC therapy to overcome the drug resistance
Swastika Maity, K. Sreedhara Ranganath Pai, Yogendra Nayak
Pharmacological Reports (2020) Vol. 72, Iss. 4, pp. 799-813
Open Access | Times Cited: 54
Swastika Maity, K. Sreedhara Ranganath Pai, Yogendra Nayak
Pharmacological Reports (2020) Vol. 72, Iss. 4, pp. 799-813
Open Access | Times Cited: 54
Implicative role of epidermal growth factor receptor and its associated signaling partners in the pathogenesis of Alzheimer’s disease
Pavan K. Jayaswamy, M. Vijaykrishnaraj, Prakash Patil, et al.
Ageing Research Reviews (2022) Vol. 83, pp. 101791-101791
Closed Access | Times Cited: 32
Pavan K. Jayaswamy, M. Vijaykrishnaraj, Prakash Patil, et al.
Ageing Research Reviews (2022) Vol. 83, pp. 101791-101791
Closed Access | Times Cited: 32
A novel bispecific antibody drug conjugate targeting HER2 and HER3 with potent therapeutic efficacy against breast cancer
Huifang Zong, Xi Li, Lei Han, et al.
Acta Pharmacologica Sinica (2024) Vol. 45, Iss. 8, pp. 1727-1739
Closed Access | Times Cited: 8
Huifang Zong, Xi Li, Lei Han, et al.
Acta Pharmacologica Sinica (2024) Vol. 45, Iss. 8, pp. 1727-1739
Closed Access | Times Cited: 8
Sulfonamides as anticancer agents: A brief review on sulfonamide derivatives as inhibitors of various proteins overexpressed in cancer
Khaled Elsayad, Ghada F. Elmasry, Sally Tarek Mahmoud, et al.
Bioorganic Chemistry (2024) Vol. 147, pp. 107409-107409
Closed Access | Times Cited: 7
Khaled Elsayad, Ghada F. Elmasry, Sally Tarek Mahmoud, et al.
Bioorganic Chemistry (2024) Vol. 147, pp. 107409-107409
Closed Access | Times Cited: 7
Investigating underlying molecular mechanisms, signaling pathways, emerging therapeutic approaches in pancreatic cancer
Mohd Rais Mustafa, Kashif Abbas, Mudassir Alam, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 6
Mohd Rais Mustafa, Kashif Abbas, Mudassir Alam, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 6
Facile Synthesis of Cyclic Peptide–Phthalocyanine Conjugates for Epidermal Growth Factor Receptor-Targeted Photodynamic Therapy
Jacky C. H. Chu, Wing‐Ping Fong, Clarence T. T. Wong, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 4, pp. 2064-2076
Closed Access | Times Cited: 30
Jacky C. H. Chu, Wing‐Ping Fong, Clarence T. T. Wong, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 4, pp. 2064-2076
Closed Access | Times Cited: 30
Design and synthesis of novel quinazolinone-based derivatives as EGFR inhibitors with antitumor activity
Amr Sonousi, Rasha A. Hassan, Eman O. Osman, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2022) Vol. 37, Iss. 1, pp. 2644-2659
Open Access | Times Cited: 19
Amr Sonousi, Rasha A. Hassan, Eman O. Osman, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2022) Vol. 37, Iss. 1, pp. 2644-2659
Open Access | Times Cited: 19
Regulation of Signaling from the Epidermal Growth Factor Family
Antony W. Burgess
The Journal of Physical Chemistry B (2022) Vol. 126, Iss. 39, pp. 7475-7485
Closed Access | Times Cited: 19
Antony W. Burgess
The Journal of Physical Chemistry B (2022) Vol. 126, Iss. 39, pp. 7475-7485
Closed Access | Times Cited: 19
LPS-induced extracellular AREG triggers macrophages pyroptosis through EGFR/TLR4 signaling pathway
Gang Yuan, Qian Qiao, Aolin Jiang, et al.
Research Square (Research Square) (2025)
Closed Access
Gang Yuan, Qian Qiao, Aolin Jiang, et al.
Research Square (Research Square) (2025)
Closed Access
Epidermal growth factor-mediated suppression of long noncoding RNA LINC01089 prevents proliferation, migration and invasion of epithelial ovarian cancer
Min Qian, Duanrong Zhu, Lu Yang
Inorganic Chemistry Communications (2025), pp. 114027-114027
Closed Access
Min Qian, Duanrong Zhu, Lu Yang
Inorganic Chemistry Communications (2025), pp. 114027-114027
Closed Access
Leveraging HER2-targeted Biparatopic Antibodies in Solid Tumors
Xinlin Liu, Xinyi Fan, Xiang Gao, et al.
Pharmacological Research (2025) Vol. 214, pp. 107687-107687
Open Access
Xinlin Liu, Xinyi Fan, Xiang Gao, et al.
Pharmacological Research (2025) Vol. 214, pp. 107687-107687
Open Access
Extensive Review of Nanomedicine Strategies Targeting the Tumor Microenvironment in PDAC
Xing Liu, Yidan Shao, Yunjiang Li, et al.
International Journal of Nanomedicine (2025) Vol. Volume 20, pp. 3379-3406
Open Access
Xing Liu, Yidan Shao, Yunjiang Li, et al.
International Journal of Nanomedicine (2025) Vol. Volume 20, pp. 3379-3406
Open Access
LPS-induced extracellular AREG triggers macrophage pyroptosis through the EGFR/TLR4 signaling pathway
Gang Yuan, Qian Qiao, Aolin Jiang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Gang Yuan, Qian Qiao, Aolin Jiang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Oxaloacetate stimulates phosphorylation of epidermal growth factor receptor in epithelial cells in vitro
Ye Kuang, Yuxiang Zhao, Zeyu Miao, et al.
Growth Factors (2025), pp. 1-13
Closed Access
Ye Kuang, Yuxiang Zhao, Zeyu Miao, et al.
Growth Factors (2025), pp. 1-13
Closed Access